NASDAQ:JAZZ

Jazz Pharmaceuticals Stock News

etoro logo Buy JAZZ
*Your capital is at risk
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Moody's Investors Service commented that Jazz Pharmaceuticals plc's recent increase in debt to add cash to the balance sheet for general corporate purposes is credit negative due to higher financial l
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals") today announced the pricing of $850 million aggregate principal amount of 2.000% exchangeable senior notes due 2026 in a private offeri
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to offer, subject to market conditions and other factors, $
In this article we will take a look at whether hedge funds think Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) is a good investment right now. We check hedge fund and billionaire investor sentiment before de
In this article we will take a look at whether hedge funds think Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) is a good investment right now. We check hedge fund and billionaire investor sentiment before de
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Top Insider Buys Highlight for the Week of May 29

10:01pm, Saturday, 30'th May 2020
Insiders loaded up on TJX Companies, Boston Properties, Royal Caribbean Cruises and Jazz Pharmaceuticals Continue reading...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following virtual investor conferences:
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its partners will present seven new abstracts at the virtual American Society of Clinical Oncology (ASCO) Annual Meeting from May 29
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE